Nov 15, 2024
Did you miss CEO Hanna Sjöström’s investor presentation at the Redeye Theme: Medtech & Diagnostics Event 2024? Don’t worry—you can still catch up on all the exciting updates! In her presentation, CEO Hanna Sjöström highlighted Neola Medical’s significant...
Nov 11, 2024
Photo: Professor Christian Speer, CEO Hanna Sjöström, CTO Sara Bergsten, Professor Christoph Härtel and Director QA & RA Magnus Johnsson Neola Medical was honored to have the esteemed U.S. Professor Vineet Bhandari, Division Head in Neonatology at The Children’s...
Nov 8, 2024
Did you miss the Redeye interview with CEO Hanna Sjöström following the release of the Q3 2024 report? Watch the interview below:
Nov 6, 2024
Watch when CEO Hanna Sjöström and CFO David Folkesson presented Neola Medical’s Q3-report of 2024. Learn more about the company’s financial position and the progress from this quarter, toward market approval in the U.S. After the presentation a brief Q&A follows....
Oct 28, 2024
Redeye initiates coverage of Neola Medical with a fair value estimate of SEK 3.1 per share in the base case scenario and SEK 5.8 per share in the bull case scenario. Read the entire coverage report by Redeye here: Redeye coverage report of Neola Medical
Oct 22, 2024
CEO Hanna Sjöström had the pleasure of sharing Neola Medical’s inspiring journey—from groundbreaking research at Lund University, to becoming a startup at Medicon Village, to scaling up as a NOME graduate. A huge thank you to Medicon Village and the Nordic Mentor...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPersonal Data Policy
